237 related articles for article (PubMed ID: 28958808)
1. Human innate responses and adjuvant activity of TLR ligands in vivo in mice reconstituted with a human immune system.
Cheng L; Zhang Z; Li G; Li F; Wang L; Zhang L; Zurawski SM; Zurawski G; Levy Y; Su L
Vaccine; 2017 Oct; 35(45):6143-6153. PubMed ID: 28958808
[TBL] [Abstract][Full Text] [Related]
2. Distinct TLR adjuvants differentially stimulate systemic and local innate immune responses in nonhuman primates.
Kwissa M; Nakaya HI; Oluoch H; Pulendran B
Blood; 2012 Mar; 119(9):2044-55. PubMed ID: 22246032
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses.
Loré K; Betts MR; Brenchley JM; Kuruppu J; Khojasteh S; Perfetto S; Roederer M; Seder RA; Koup RA
J Immunol; 2003 Oct; 171(8):4320-8. PubMed ID: 14530357
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands.
Grossmann C; Tenbusch M; Nchinda G; Temchura V; Nabi G; Stone GW; Kornbluth RS; Uberla K
BMC Immunol; 2009 Aug; 10():43. PubMed ID: 19650904
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific.
Wu J; Meng Z; Jiang M; Zhang E; Trippler M; Broering R; Bucchi A; Krux F; Dittmer U; Yang D; Roggendorf M; Gerken G; Lu M; Schlaak JF
Immunology; 2010 Mar; 129(3):363-74. PubMed ID: 19922426
[TBL] [Abstract][Full Text] [Related]
6. Expression and function of Toll-like receptors on dendritic cells and other antigen presenting cells from non-human primates.
Ketloy C; Engering A; Srichairatanakul U; Limsalakpetch A; Yongvanitchit K; Pichyangkul S; Ruxrungtham K
Vet Immunol Immunopathol; 2008 Sep; 125(1-2):18-30. PubMed ID: 18571243
[TBL] [Abstract][Full Text] [Related]
7. TLR ligands in the local treatment of established intracerebral murine gliomas.
Grauer OM; Molling JW; Bennink E; Toonen LW; Sutmuller RP; Nierkens S; Adema GJ
J Immunol; 2008 Nov; 181(10):6720-9. PubMed ID: 18981089
[TBL] [Abstract][Full Text] [Related]
8. CpG-ODN but not other TLR-ligands restore the antitumor responses in old mice: the implications for vaccinations in the aged.
Sharma S; Dominguez AL; Hoelzinger DB; Lustgarten J
Cancer Immunol Immunother; 2008 Apr; 57(4):549-61. PubMed ID: 17828396
[TBL] [Abstract][Full Text] [Related]
9. Species-dependent role of type I IFNs and IL-12 in the CTL response induced by humanized CpG complexed with β-glucan.
Kobiyama K; Temizoz B; Kanuma T; Ozasa K; Momota M; Yamamoto T; Aoshi T; Kuroda E; Ishii KJ
Eur J Immunol; 2016 May; 46(5):1142-51. PubMed ID: 26786557
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor ligands directly promote activated CD4+ T cell survival.
Gelman AE; Zhang J; Choi Y; Turka LA
J Immunol; 2004 May; 172(10):6065-73. PubMed ID: 15128790
[TBL] [Abstract][Full Text] [Related]
11. Human B cell responses to TLR ligands are differentially modulated by myeloid and plasmacytoid dendritic cells.
Douagi I; Gujer C; Sundling C; Adams WC; Smed-Sörensen A; Seder RA; Karlsson Hedestam GB; Loré K
J Immunol; 2009 Feb; 182(4):1991-2001. PubMed ID: 19201852
[TBL] [Abstract][Full Text] [Related]
12. Immunization with HIV-1 Gag protein conjugated to a TLR7/8 agonist results in the generation of HIV-1 Gag-specific Th1 and CD8+ T cell responses.
Wille-Reece U; Wu CY; Flynn BJ; Kedl RM; Seder RA
J Immunol; 2005 Jun; 174(12):7676-83. PubMed ID: 15944268
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses.
Dowling DJ; Scott EA; Scheid A; Bergelson I; Joshi S; Pietrasanta C; Brightman S; Sanchez-Schmitz G; Van Haren SD; Ninković J; Kats D; Guiducci C; de Titta A; Bonner DK; Hirosue S; Swartz MA; Hubbell JA; Levy O
J Allergy Clin Immunol; 2017 Nov; 140(5):1339-1350. PubMed ID: 28343701
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Innate Responses Induced by PLGA Encapsulated- and Soluble TLR Ligands In Vitro and In Vivo in Chickens.
Alkie TN; Taha-Abdelaziz K; Barjesteh N; Bavananthasivam J; Hodgins DC; Sharif S
PLoS One; 2017; 12(1):e0169154. PubMed ID: 28045984
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant.
Longhi MP; Trumpfheller C; Idoyaga J; Caskey M; Matos I; Kluger C; Salazar AM; Colonna M; Steinman RM
J Exp Med; 2009 Jul; 206(7):1589-602. PubMed ID: 19564349
[TBL] [Abstract][Full Text] [Related]
16. Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity.
Tacken PJ; Zeelenberg IS; Cruz LJ; van Hout-Kuijer MA; van de Glind G; Fokkink RG; Lambeck AJ; Figdor CG
Blood; 2011 Dec; 118(26):6836-44. PubMed ID: 21967977
[TBL] [Abstract][Full Text] [Related]
17. TLR9- and CD40-Targeting Vaccination Promotes Human B Cell Maturation and IgG Induction
Cheng L; Li G; Pellegry CM; Yasui F; Li F; Zurawski SM; Zurawski G; Levy Y; Ting JP; Su L
Front Immunol; 2021; 12():672143. PubMed ID: 34093572
[TBL] [Abstract][Full Text] [Related]
18. Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets.
Tel J; Schreibelt G; Sittig SP; Mathan TS; Buschow SI; Cruz LJ; Lambeck AJ; Figdor CG; de Vries IJ
Blood; 2013 Jan; 121(3):459-67. PubMed ID: 23212525
[TBL] [Abstract][Full Text] [Related]
19. Identification of immune factors regulating antitumor immunity using polymeric vaccines with multiple adjuvants.
Ali OA; Verbeke C; Johnson C; Sands RW; Lewin SA; White D; Doherty E; Dranoff G; Mooney DJ
Cancer Res; 2014 Mar; 74(6):1670-81. PubMed ID: 24480625
[TBL] [Abstract][Full Text] [Related]
20. Systemic immune activation in HIV infection is associated with decreased MDC responsiveness to TLR ligand and inability to activate naive CD4 T-cells.
Yonkers NL; Rodriguez B; Asaad R; Lederman MM; Anthony DD
PLoS One; 2011; 6(9):e23884. PubMed ID: 21912648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
